Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA. The Company has assembled a toolkit of disruptive platform technologies – including a high payload capacity HSV platform, a hypoimmunogenic platform, and a genome writing platform – to address the scientific challenges currently limiting clinical progress and preventing genomic medicine from realising its full potential. The Company’s hub-and-spoke business model separates technology development within Replay from therapeutic development in product companies, which leverage the technology platforms. For example, Replay’s synHSV™ technology, a high payload capacity HSV vector capable of delivering up to 30 times the payload of AAV, is utilized by Replay’s four gene therapy product companies, bringing big DNA treatments to diseases affecting the skin, eye, brain, and muscle. The Company has, additionally, established an enzyme writing product company engaging its evolutionary inference machine learning and genome writing technology to optimize functionality. Replay is led by a world-class team of academics, entrepreneurs and industry experts.
Company Details
- Employees
- 33
- Founded
- -
- Address
- 5555 Oberlin Dr, San Diego,california 92121,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.replay.bio
- Keywords
- Genome writing, Enzyme writing, Gene therapy, Gene editing, Transcriptional regulation, Hypo-immunogenic cell therapy.
- HQ
- San Diego, California
Replay Questions
Replay's website is http://www.replay.bio
Replay's LinkedIn profile is https://www.linkedin.com/company/replay-bio
Replay has
33 employees.
View email and phone details for 33
employees at Replay.
Replay's industry is
Biotechnology Research
Replay's top competitors are
Shoreline Biosciences, Inc.,
Reply,
Debut,
Genyro Inc,
Strand Therapeutics,
Replay,
Replay,
Orgagen Biosciences,
Replay,
Replicate Bioscience, Inc..
Replay's categories are Biotechnology Research
Replay's founding year is 2021
